ArticleBMC medical imaging2024
Enhancing classification of active and non-active lesions in multiple sclerosis: machine learning models and feature selection techniques.
Article in BMC medical imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Artificial Intelligence for Gadolinium-Sparing Detection of Active Multiple Sclerosis Lesions: A Structured Narrative Review.Neurology and therapy · 2026Review
- Machine learning in neuroradiology: Recent developments and applications.World journal of radiology · 2026Review
- A Robust Dual-Stage Learning-Based Pipeline for Multiclass Segmentation of Multiple Sclerosis Lesions in MRI.Diagnostics (Basel, Switzerland) · 2026Article
- Synthetic MRI and radiomics in multiple sclerosis: improving precision in diagnosis and prognosis.Radiological physics and technology · 2026Review
- Patch Uniform Fusion Transformer with circle-inspired optimized walrus-based feature selection for high-dimensional data analysis.Journal of molecular modeling · 2026Article
- IVIM-DWI-Based Radiomics for Lesion Phenotyping and Clinical Status Prediction in Relapsing-Remitting Multiple Sclerosis.Journal of clinical medicine · 2025Article
- SeruNet-MS: A Two-Stage Interpretable Framework for Multiple Sclerosis Risk Prediction with SHAP-Based Explainability.Neurology international · 2025Article
- Machine learning-based classification of multiple sclerosis lesion activity using multi-sequence MRI radiomics: a complete analysis of T1, T2, FLAIR, DWI, and SWI features.Polish journal of radiology · 2025Article
- Predicting multiple sclerosis prognosis using AI and machine learning: integrating clinical, immunological, and radiological variables.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGadolinium-based T1-weighted MRI sequence is the gold standard for the detection of active multiple sclerosis (MS) lesions. The performance of machine learning (ML) and deep learning (DL) models in the classification of active and non-active MS lesions from the T2-weighted MRI images has been investigated in this study.
methods107 Features of 75 active and 100 non-active MS lesions were extracted by using SegmentEditor and Radiomics modules of 3D slicer software. Sixteen ML and one sequential DL models were created using the 5-fold cross-validation method and each model with its special optimized parameters trained using the training-validation datasets. Models' performances in test data set were evaluated by metric parameters of accuracy, precision, sensitivity, specificity, AUC, and F1 score.
resultsThe sequential DL model achieved the highest AUC of 95.60% on the test dataset, demonstrating its superior ability to distinguish between active and non-active plaques. Among traditional ML models, the Hybrid Gradient Boosting Classifier (HGBC) demonstrated a commendable test AUC of 86.75%, while the Gradient Boosting Classifier (GBC) excelled in cross-validation with an AUC of 87.92%.
conclusionThe performance of sixteen ML and one sequential DL models in the classification of active and non-active MS lesions was evaluated. The results of the study highlight the effectiveness of sequential DL approach and ensemble methods in achieving robust predictive performance, underscoring their potential applications in classifying MS plaques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.